Expression profiling--best practices for data generation and interpretation in clinical trials.
about
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1Microarrays and breast cancer clinical studies: forgetting what we have not yet learntGEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression dataEndothelial cell activation and neovascularization are prominent in dermatomyositisQuality assurance of RNA expression profiling in clinical laboratoriesPSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancerImpact of delay to cryopreservation on RNA integrity and genome-wide expression profiles in resected tumor samplesRelationship between gene expression and lung function in Idiopathic Interstitial Pneumonias.The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.Empirical validation of the S-Score algorithm in the analysis of gene expression data.Translating microarray data for diagnostic testing in childhood leukaemia.Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junction.Integrated molecular portrait of non-small cell lung cancers.Microarray scanner calibration curves: characteristics and implications.Identification of candidate mRNAs associated with gonadotropin-induced maturation of murine cumulus oocyte complexes using serial analysis of gene expression.Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer.A non-parametric meta-analysis approach for combining independent microarray datasets: application using two microarray datasets pertaining to chronic allograft nephropathy.Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies.Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling.Quality assessment of microarray data in a multicenter study.Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples.Quality control in microarray assessment of gene expression in human airway epitheliumReversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary diseaseStandards affecting the consistency of gene expression arrays in clinical applications.African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.Application of genome-wide expression analysis to human health and disease.Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo.Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma.The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertensionEstimating RNA-quality using GeneChip microarrays.A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness.Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphomaDysplasia-carcinoma transition specific transcripts in colonic biopsy samples.
P2860
Q24299685-8A09EA5E-31EB-460D-933C-3292C329AE4BQ24810271-9A51D352-0E8A-4526-9EEE-78986F899DF7Q24813561-47E5E824-94C1-43E0-A83A-0A7FD9E2EAFDQ25256876-11E3C0E5-3BFC-4145-B777-B67260CEBF63Q26866455-92F3A70B-6051-43D2-A47D-381100ED21EFQ28267716-E2A16BC6-3BA6-45ED-89CC-DC4082282874Q28535315-05042A44-2468-440E-9C2A-1879A6ED84F5Q30670800-1C737250-E5AF-439E-BF83-0779E3779E14Q30939855-DEA8A1AC-BBBA-4B4F-9B85-800C6D49D3EFQ31034601-66FFE9F0-69B3-4A76-9252-86977985C485Q31062604-C032A843-9E0B-41B1-873A-C0C1AA8DD85DQ31119076-C19FFA7C-C031-4E98-A039-358538922DA2Q31137838-4A96B5BE-B80B-4CA4-B53A-50E97F3390F2Q31145455-ABA7BFC4-31A5-4C06-86FD-1517FF87186EQ33219774-4AAD30A3-15F1-4365-B3CD-38E24C85981DQ33254105-EFDEC187-1AA4-4B0A-8D4E-A1912929E2B8Q33279572-4610C99B-CE24-41BE-8C96-6100A7AF82B9Q33321328-EDB247CD-6E93-4B6B-A08A-E27F5AAB7D79Q33356785-257873E3-384B-497E-AC31-9D62D4BE0AFBQ33369599-2A2F0E18-BFA1-4A27-A2D3-709FAA3A9BABQ33373057-16648329-B9E1-469E-ADAA-3DBB783BE405Q33408751-F8B9F93D-1756-40DE-9E13-D643AC7C6964Q33450671-44DB344F-1898-48FE-972D-812DDC18D7B9Q33512143-2D0A95F8-E8D9-47F2-AD72-AA04BAFD9D6AQ33723633-5C436528-DA31-4F66-85F5-7D2622CE3B12Q33766550-E4BAAD50-7D42-4DA0-9739-27888D65C2FBQ33780759-FBEB40C1-490D-4EE6-A795-C42475C92B7AQ33814348-99063423-B78D-460B-A9A1-2CEB2FC371B7Q33933146-B6C2837F-2D2E-4641-AABB-EC383CFF9725Q33978011-453D520F-DD40-4CD1-9E53-AB4E6EEF7B39Q33988433-4FE3CEC1-CFB7-4824-8A1F-B7D661BE51A5Q34142332-14E70A33-800F-4BF1-9B51-754DD0066371Q34181948-444813F1-297F-431E-8C95-AD453E3AE368Q34250971-4E9C0CCC-C433-412A-8FA6-9C275214DBABQ34268387-41D09814-2B10-48F4-A41E-75DD961CEDCEQ34274225-E939A4A9-1C13-4005-952E-963E57560992Q34276100-89850C1B-6644-4B34-80FF-527134AE1627Q34332718-C0A663E3-BD79-4471-B077-73FD7EF2F36BQ34427855-47649387-3334-4A35-9A66-E8FDBA70F68FQ34479019-712DCB78-B9FF-4903-B090-7F9D20131E5C
P2860
Expression profiling--best practices for data generation and interpretation in clinical trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression profiling--best pra ...... rpretation in clinical trials.
@en
Expression profiling--best pra ...... rpretation in clinical trials.
@nl
type
label
Expression profiling--best pra ...... rpretation in clinical trials.
@en
Expression profiling--best pra ...... rpretation in clinical trials.
@nl
prefLabel
Expression profiling--best pra ...... rpretation in clinical trials.
@en
Expression profiling--best pra ...... rpretation in clinical trials.
@nl
P356
P1476
Expression profiling--best pra ...... rpretation in clinical trials.
@en
P2093
Tumor Analysis Best Practices Working Group
P2888
P304
P356
10.1038/NRG1297
P577
2004-03-01T00:00:00Z